Act 217, SB 875 – Relating to: excepting xylazine testing materials from the definition of drug paraphernalia and civil and criminal liability exemptions for distributing and administering xylazine testing products
Linked as:
Extract
Act 217, SB 875 – Relating to: excepting xylazine testing materials from the definition of drug paraphernalia and civil and criminal liability exemptions for distributing and administering xylazine testing products
No longer available (Autolink)
See the full content of this document
